Skip to main content
Quest Diagnostics

False Positive Results for the CEDIA™ Mitragynine Immunoassay Caused by Methadone and EDDP in Clinical Specimens

ADLM 2025

Association for Diagnostics and Laboratory medicine

Chicago, IL, July 27-31 , 2025

Poster presentation: False Positive Results for the CEDIA™ Mitragynine Immunoassay Caused by Methadone and EDDP in Clinical Specimens

Authors: Cheng VZ, Chen L

Medical Specialty: Prescription Drug Monitoring, Toxicology, Immunology, Laboratory medicine

Related content

Audio Podcast
Kratom: Identifying “A Drug of Concern”
Audio Podcast
Novel Psychoactive Substances (NPS): A Dangerous, Widespread Public Health Issue
Test FAQ
Drug Testing General Toxicology Blood or Serum
On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Test FAQ
Drug Monitoring, Assess Panel, Comprehensive, Qualitative, Urine

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.